Canada Neurology Devices Market Size (2024 - 2029)

The Canadian neurology devices market is poised for significant growth, driven by an increasing prevalence of neurological disorders and a rising geriatric population. The market's expansion is further supported by advancements in neurotherapy research and development, alongside investments in sophisticated healthcare infrastructure. Despite the challenges posed by stringent regulations, the market is expected to recover and grow as neurological services resume post-pandemic. The development and adoption of advanced neurovascular devices are also contributing to the market's positive trajectory, addressing the healthcare needs of the aging population in Canada.

Market Size of Canada Neurology Devices Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Canada Neurology Devices Market Summary
Study Period 2021 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
Historical Data Period 2021 - 2022
CAGR 7.50 %

Major Players

Canada Neurology Devices Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Canada Neurology Devices Market Analysis

The Canadian neurology devices market is expected to register a CAGR of 7.5% over the forecast period.

The COVID-19 pandemic negatively impacted Canada's neurology devices market. In November 2021, an article published in Parkinsonism and Related Disorder reported a 17% reduction in deep brain stimulation surgeries in Canada during the initial 4 to 16 weeks of COVID-19. This was due to the cancellation of hospital appointments due to an increase in COVID-19 cases. However, in the upcoming years, it is anticipated that the declining COVID-19 infection rates will lead to the resumption of neurological services in hospitals and clinics. As a result, the market is expected to witness stable growth over the forecast period.

The factors driving the growth of the studied market are the growing burden of neurological disorders, the increasing geriatric population, and the increase in R&D in the field of neurotherapy. The elderly population is vulnerable to several neurological conditions, such as stroke, dementia, Parkinson's disease, tremor, and epilepsy, constantly increasing the demand for neurology devices. For instance, in August 2022, Statistics Canada reported that in 2021, 18.5% of the population in Canada aged above 65 years. Similarly, in September 2022, Alzheimer's Society reported that 5,69,600 Canadians were living with dementia in 2020, and this number is expected to increase to 9,55,900 by 2030. Thus, the high geriatric population and the increasing neurological disorder associated with them is driving the demand for neurological devices.

The rising investments in the development of sophisticated healthcare infrastructure and rising investments by the corporate in R&D activities have led to the development and increased adoption of neurovascular devices. The availability of advanced treatments for various neurological disorders owing to the presence of technologically advanced neurovascular devices has significantly contributed to market growth. For instance, in September 2022, Axonics reported one of the first patients got an implant for its Axonics F15 sacral neuromodulation (SNM) system in Canada. Thus, the development of various neurology devices is providing better treatment to people in the country living with neurological disorders and are driving the growth of the studied market in the country.

Thus, due to the growing burden of neurological disorders, the increasing geriatric population, and the increase in R&D in the field of neurotherapy, the studied market is expected to witness significant growth over the forecast period. However, stringent regulations and guidelines for new devices may slow down the development of the studied market.

Canada Neurology Devices Industry Segmentation

Neurological devices help diagnose, prevent, and treat various neurological disorders and conditions, such as Alzheimer's, Parkinson's, major depression, and traumatic brain injury.

The Canadian Neurology Devices Market is Segmented by Type of Device (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices, Neurosurgery Devices, Neurostimulation Devices, and Other Types of Devices). The report offers the value (in USD million) for the above segments.

By Type of Device
Cerebrospinal Fluid Management Devices
Interventional Neurology Devices
Neurosurgery Devices
Neurostimulation Devices
Other Types of Devices
Need A Different Region Or Segment?
Customize Now

Canada Neurology Devices Market Size Summary

The Canadian neurology devices market is poised for substantial growth, driven by the increasing prevalence of neurological disorders and a rising geriatric population. The market's expansion is supported by advancements in neurotherapy research and development, which are crucial in addressing the growing demand for neurology devices. The market experienced a temporary setback due to the COVID-19 pandemic, which led to a reduction in neurological procedures. However, as infection rates decline, the resumption of services is expected to stabilize and propel market growth. The development and adoption of advanced neurovascular devices have significantly enhanced treatment options for neurological conditions, further contributing to market dynamics.

The market is characterized by a competitive landscape with key players such as B. Braun Melsungen AG, Boston Scientific Corporation, and Medtronic PLC, among others. The neurosurgery devices segment is anticipated to grow due to the increasing number of minimally invasive surgical procedures and the aging population, which is more susceptible to neurological disorders. Additionally, the neurostimulation devices segment is expected to expand, fueled by the prevalence of chronic pain and neurological conditions. Innovations like the NeuroSphere virtual clinic by Abbott Laboratories exemplify the industry's commitment to enhancing patient access to advanced treatments. Overall, the Canadian neurology devices market is set to experience significant growth, driven by technological advancements and demographic trends.

Explore More

Canada Neurology Devices Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Growing Burden of Neurological Disorders and Increasing Geriatric Population

      2. 1.2.2 Increase in R&D Development in Neurological Devices

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulations and Guidelines for New Devices

    4. 1.4 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Type of Device

      1. 2.1.1 Cerebrospinal Fluid Management Devices

      2. 2.1.2 Interventional Neurology Devices

      3. 2.1.3 Neurosurgery Devices

      4. 2.1.4 Neurostimulation Devices

      5. 2.1.5 Other Types of Devices

Canada Neurology Devices Market Size FAQs

The Canada Neurology Devices Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)

B. Braun Melsungen AG, Boston Scientific Corporation, Stryker Corporation, Medtronic PLC and Abbott Laboratories are the major companies operating in the Canada Neurology Devices Market.

Canada Neurology Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)